FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Nov 8, 2019
FDA inspection 1111119 · Voluntary Action Indicated (VAI) · Menakuru
Key facts
| Inspection ID | 1111119 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3011895410 |
| Address | Plot 16, Apiic Multiproduct Sez; Unit X |
| City | Menakuru |
| Fiscal year | 2020 |
| Inspection end date | Nov 8, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data